ExamFinch.com My Study

Study guide

6.2 Hemodynamic Monitoring: Arterial Lines, CVP & Pulmonary Artery Catheter

Practice this exam

ABIM Critical Care Medicine Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Orientation: Format, Blueprint & Study Strategy

1.1 ABIM Critical Care Medicine Exam: Format, Blueprint & Study Strategy

2 Chapter 2: Acute Respiratory Failure & ARDS

2.1 ARDS Definition, Pathophysiology & Phenotypes 2.2 Lung-Protective Mechanical Ventilation 2.3 Refractory ARDS: Prone Positioning, Neuromuscular Blockade & VV-ECMO

3 Chapter 3: Obstructive Airways, Pulmonary Vascular & Pleural Emergencies

3.1 Severe Asthma & COPD Exacerbations in the ICU 3.2 Massive & Submassive Pulmonary Embolism 3.3 Pulmonary Hypertension & Right Ventricular Failure in the ICU 3.4 Massive Hemoptysis, Complex Pleural Effusions & Thoracic Drainage

4 Chapter 4: Airway, Parenchymal & Nonthrombotic Pulmonary Emergencies

4.1 Airway Management, Upper-Airway Obstruction & Artificial-Airway Complications 4.2 Diffuse Alveolar Hemorrhage, Interstitial Lung Disease, Pulmonary Vasculitis & Noncardiogenic Edema 4.3 Severe Community-Acquired & Viral Pneumonia 4.4 Nonthrombotic Embolism (Air, Fat, Amniotic Fluid, Tumor, Septic) & Acute Chest Syndrome

5 Chapter 5: Mechanical Ventilation Modes, Dyssynchrony & Liberation

5.1 Mechanical Ventilator Modes & Advanced Breath Delivery 5.2 Patient-Ventilator Dyssynchrony & Waveform Analysis 5.3 Ventilator Liberation, Spontaneous Breathing Trials & Post-Extubation Support

6 Chapter 6: Shock Syndromes & Hemodynamic Principles

6.1 Shock Classification, Cellular Pathophysiology & Biomarkers 6.2 Hemodynamic Monitoring: Arterial Lines, CVP & Pulmonary Artery Catheter 6.3 Dynamic Assessment of Fluid Responsiveness & Resuscitation Targets

7 Chapter 7: Vasoactive Therapies & Mechanical Circulatory Support

7.1 Vasopressors & Inotropes: Pharmacology & Clinical Titration 7.2 Temporary Mechanical Circulatory Support: IABP, Impella & TandemHeart 7.3 Venoarterial ECMO (VA-ECMO) & Differential Hypoxemia 7.4 Post-Cardiac Arrest Care, Targeted Temperature Management & Neuroprognostication

8 Chapter 8: Acute Kidney Injury & Renal Replacement Therapy

8.1 KDIGO AKI Classification, Etiologies & Diagnostic Evaluation 8.2 Continuous Renal Replacement Therapy (CRRT) vs Intermittent Hemodialysis 8.3 Indications & Timing for RRT in Critical Illness: AKIKI & STARRT-AKI

9 Chapter 9: Electrolyte, Acid-Base & Endocrine Emergencies

9.1 Severe Dysnatremias: Hyponatremia, Hypernatremia & Osmotic Demyelination 9.2 Potassium, Calcium, Magnesium & Phosphate Disorders 9.3 Complex & Mixed Acid-Base Disorders: Boston vs Copenhagen vs Stewart 9.4 Endocrine Crises: DKA, HHS, Thyroid Storm, Myxedema Coma & Adrenal Crisis

10 Chapter 10: Glycemic Control, Hyperammonemia, Pituitary & Adrenal Disorders

10.1 ICU Glycemic Control & Severe Hypoglycemia 10.2 Non-Hepatic Hyperammonemia & Metabolic Encephalopathy 10.3 Pituitary Emergencies, Adrenal Excess & Critical Illness-Related Corticosteroid Insufficiency

11 Chapter 11: Acute Coronary Syndromes & Cardiac Arrhythmias

11.1 Acute Coronary Syndromes & Mechanical Complications of Myocardial Infarction 11.2 Critical Tachyarrhythmias: Atrial Fibrillation with RVR, VT & VF 11.3 Critical Bradyarrhythmias, Conduction Blocks & Temporary Cardiac Pacing

12 Chapter 12: Acute Heart Failure, Valvular & Pericardial Emergencies

12.1 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 12.2 Acute Valvular Regurgitation & Prosthetic Valve Emergencies 12.3 Pericardial Tamponade & Acute Aortic Syndromes

13 Chapter 13: Myocardial Disease, Hypertensive & Cardiac Device Emergencies

13.1 Fulminant Myocarditis, Stress & Peripartum Cardiomyopathy, and Hypertrophic Cardiomyopathy 13.2 Hypertensive Emergencies & Ruptured Abdominal Aortic Aneurysm 13.3 Implanted Cardiac Devices, LVAD Emergencies & Electrical Storm

14 Chapter 14: Sepsis & Systemic Infectious Diseases

14.1 Sepsis-3 Definitions & Surviving Sepsis Campaign 2026 Guidelines 14.2 Refractory Septic Shock & Adjunctive Therapies 14.3 Multidrug-Resistant Pathogens & Antimicrobial Stewardship in the ICU

15 Chapter 15: ICU-Acquired & Severe Focal Infections

15.1 Hospital-Acquired & Ventilator-Associated Pneumonia 15.2 Central Line-Associated Bloodstream Infections & Catheter-Associated UTIs 15.3 Intra-Abdominal Sepsis, Necrotizing Soft Tissue Infections & CNS Infections

16 Chapter 16: Focal, Special-Host & Systemic Infections

16.1 CNS Infections Beyond Bacterial Meningitis: Encephalitis, Brain Abscess & Epidural Abscess 16.2 Infections in the Immunocompromised Host, Tropical & Bioterror Infections 16.3 Infective Endocarditis, Device Infections & Other Focal Cardiovascular Infections 16.4 Antimicrobial Pharmacokinetics, Allergy, Toxicity & Infection Prevention 16.5 Gastrointestinal & Hepatobiliary Infections: Fulminant C. difficile, Typhlitis, CMV Colitis & Abscesses

17 Chapter 17: Neurocritical Care & Coma

17.1 Coma, Altered Mental Status & Acute Delirium in the ICU 17.2 Status Epilepticus & Non-Convulsive Status Epilepticus 17.3 Acute Ischemic Stroke & Intracranial Hemorrhage

18 Chapter 18: Cerebrovascular Syndromes, Encephalopathy & Withdrawal States

18.1 Cerebral Venous Sinus Thrombosis, PRES & Reversible Cerebral Vasoconstriction Syndrome 18.2 Alcohol & Sedative Withdrawal, Wernicke Encephalopathy & Drug-Induced Encephalopathy

19 Chapter 19: Intracranial Hypertension & Neuromuscular Weakness

19.1 Intracranial Pressure Monitoring, Cerebral Perfusion & Tiered ICP Management 19.2 Acute Neuromuscular Respiratory Failure, ICU-Acquired Weakness & Brain Death Determination

20 Chapter 20: Traumatic Brain Injury, Spinal Cord Injury & Toxin-Mediated Paralysis

20.1 Traumatic Brain Injury Management & Paroxysmal Sympathetic Hyperactivity 20.2 Acute Spinal Cord Injury, Neurogenic Shock & Autonomic Dysreflexia 20.3 Toxin-Mediated Paralysis & Neuromuscular Crises: Botulism, Tetanus, Tick Paralysis & Myasthenic Crisis

21 Chapter 21: Gastrointestinal, Hepatic & Abdominal Emergencies

21.1 Acute Upper & Lower Gastrointestinal Bleeding in the ICU 21.2 Acute Liver Failure & Severe Acute Pancreatitis 21.3 Abdominal Compartment Syndrome & Acute Mesenteric Ischemia

22 Chapter 22: Luminal GI Emergencies & Complications of Cirrhosis

22.1 Esophageal, Gastric & Bowel Emergencies: Perforation, Obstruction, Ogilvie Syndrome & Colonic Ischemia 22.2 Complications of Cirrhosis: Alcohol-Associated Hepatitis, Hepatorenal Syndrome & Pulmonary Vascular Syndromes

23 Chapter 23: Trauma, Burns & Perioperative Critical Care

23.1 Polytrauma Resuscitation, Damage Control & Massive Transfusion 23.2 Severe Burn Injury, Inhalation Injury & Environmental Emergencies 23.3 Perioperative Critical Care for High-Risk Surgical Patients

24 Chapter 24: Thoracic Trauma, Environmental Injury & Obstetric Critical Care

24.1 Thoracic Trauma: Flail Chest, Pulmonary Contusion, Great Vessel & Tracheobronchial Injury 24.2 Environmental Injury: Drowning, Diving, Altitude, Heat, Cold, Electrical & Radiation 24.3 Obstetric & Genitourinary Emergencies and the Physiology of Pregnancy

25 Chapter 25: Transplantation, Donor Management & Post-Cardiac Surgery Care

25.1 Solid Organ Transplant Recipients & Deceased Donor Management 25.2 Post-Cardiac Surgery Critical Care: Bleeding, Tamponade, Low Output & Vasoplegia

26 Chapter 26: Hematologic Emergencies, Toxicology, Critical Ultrasound & ICU Liberation

26.1 Hematologic Emergencies in the ICU: HIT, DIC, TMA & Anticoagulant Reversal 26.2 Critical Care Toxicology, Toxidromes & Specific Antidotes 26.3 Critical Care Point-of-Care Ultrasound (POCUS) 26.4 ICU Liberation, Analgosedation, Goals of Care & Critical Care Ethics

27 Chapter 27: Transfusion Medicine, Hematologic & Oncologic Disorders

27.1 Transfusion Medicine: Products, Thresholds, Reactions & Apheresis 27.2 Red and White Cell Disorders, Hemoglobinopathies, Factor Deficiencies & Hypercoagulable States 27.3 Oncologic Emergencies, Hematopoietic Cell Transplant Complications & Cellular Therapy Toxicity

28 Chapter 28: Clinical Pharmacology, Adverse Drug Reactions & Specific Poisonings

28.1 Pharmacokinetic Principles, Dose Adjustment & Drug Interactions in Critical Illness 28.2 Adverse Drug Reactions: Anaphylaxis, Severe Cutaneous Reactions & Hyperthermic Syndromes 28.3 Specific Poisonings: Sodium-Channel Blockers, Lithium, Valproate, Theophylline, Iron, Sulfonylureas & Methemoglobinemia

29 Chapter 29: Ethics, Research Methods, Administration & Abdominal Ultrasound

29.1 Advance Care Planning, Nonbeneficial Treatment, Informed Consent & Confidentiality 29.2 Critical Care Research Methods, Statistics, IRB Oversight & Quality Improvement 29.3 Abdominal, Vascular & Procedural Point-of-Care Ultrasound

6.2 Hemodynamic Monitoring: Arterial Lines, CVP & Pulmonary Artery Catheter

Key Takeaways Explain This Topic AI

Invasive arterial lines require precise leveling at the phlebostatic axis and square-wave fast-flush verification; underdamped systems overestimate systolic BP and underestimate diastolic BP, whereas overdamped systems underestimate systolic BP, but both preserve mean arterial pressure (MAP).

Static central venous pressure (CVP) fails to predict fluid responsiveness (AUROC ~0.56) due to wide variations in venous capacitance, right ventricular compliance, and intrathoracic pressure.

The right atrial pressure waveform consists of three positive deflections (a, c, v waves) and two descents (x and y); cannon a-waves signal atrioventricular dissociation, prominent v-waves indicate severe tricuspid regurgitation, and an absent y-descent reflects cardiac tamponade.

Pulmonary artery catheterization provides direct measurement of right heart chambers, pulmonary arterial pressures, and PCWP (approximating left ventricular end-diastolic pressure in West Zone 3), enabling precise derivation of systemic and pulmonary vascular resistance.

Mixed venous oxygen saturation (SvO2, normal 65-75%, drawn from the distal pulmonary artery) reflects global DO2/VO2 balance; central venous saturation (ScvO2, normal 70-75%, drawn from the SVC) runs 5-10% higher than SvO2 during shock states due to visceral and lower-body hypoperfusion.

Last updated: October 2026

Arterial Line Waveform Physics and Clinical Pitfalls

Continuous invasive arterial blood pressure monitoring is indicated in patients with hemodynamic instability, refractory shock requiring vasoactive infusions, frequent blood sampling requirements, or severe respiratory failure requiring serial arterial blood gases. To interpret arterial waveforms accurately, clinicians must understand the physical principles of fluid-filled catheter-transducer systems.

The Catheter-Transducer System: Natural Frequency and Damping

An arterial catheter system is a dynamic harmonic oscillator characterized by two main physical parameters:

Natural Frequency ( f n f_n f n ​ ) : The frequency at which the system oscillates freely when perturbed. In clinical systems, f n f_n f n ​ should exceed 30 − 40 Hz 30-40\text{ Hz} 30 − 40 Hz to prevent overlapping with the fundamental physiological pulse frequency ( 1 − 2 Hz 1-2\text{ Hz} 1 − 2 Hz ) and its higher harmonics.

Damping Coefficient ( ζ \zeta ζ ) : The rate at which the system dissipates energy (friction of fluid against tubing walls and transducer membranes). The optimal damping coefficient ranges from 0.6 0.6 0.6 to 0.7 0.7 0.7 .

The Fast-Flush (Square-Wave) Test

The dynamic response of the arterial monitoring system is validated at the bedside by activating the continuous flush valve (which delivers about 3 mL/h 3\text{ mL/h} 3 mL/h continuously from a bag pressurized to 300 mmHg 300\text{ mmHg} 300 mmHg ) to create a high-pressure square wave, followed by immediate release to observe the resulting oscillations:

Optimal Damping : Following the release of the flush device, the trace drops sharply below baseline, displays one to two rapid under- and overshoots (ringing), and smoothly returns to the arterial waveform. The dicrotic notch (reflecting aortic valve closure) is sharply delineated. Systolic, diastolic, and mean arterial pressures are completely accurate.

Underdamped System (Resonance) : Following the square wave, the system displays excessive oscillations ( > 3 > 3 > 3 oscillations) before returning to baseline. The system amplifies high-frequency harmonics, resulting in a falsely elevated systolic blood pressure (SBP), a falsely depressed diastolic blood pressure (DBP), and spurious overshoot spikes. Mean arterial pressure (MAP) is integrated over time and remains largely accurate. Common causes include long or excessive extension tubing (which lowers the natural frequency of the system), catheter whip, and tachycardic or hyperdynamic cardiovascular states.

Overdamped System : Following the square wave, the trace slowly returns to baseline with no post-flush oscillation (or < 1 < 1 < 1 shallow rebound), and the dicrotic notch is slurred or entirely absent. High-frequency components are blunted, causing falsely depressed SBP and falsely elevated DBP. MAP remains relatively preserved and reliable. Common causes include air bubbles within the transducer or tubing, blood clots at the catheter tip, kinks in the catheter or tubing, compliant tubing, or loose connections. Fast-Flush Dynamics:

  • Optimal Damping: ──┐┌───\_/\── (1-2 oscillations, sharp dicrotic notch)
  • Underdamped Trace: ──┐┌───\/\/\/\_ (Excessive ringing, falsely high SBP, low DBP)
  • Overdamped Trace: ──┐┌───\_______ (Slurred return, no ringing, falsely low SBP, high DBP)
  • Zeroing and Leveling at the Phlebostatic Axis

The transducer must be zeroed to atmospheric pressure and leveled to the phlebostatic axis , which corresponds to the anatomical level of the right atrium (the junction of the fourth intercostal space and the mid-anterior-posterior diameter of the chest wall in the supine position). Every 1.36 cm 1.36\text{ cm} 1.36 cm vertical displacement of the transducer above or below the phlebostatic axis introduces a measurement error of approximately 1.0 mmHg 1.0\text{ mmHg} 1.0 mmHg ( 1.0 mmHg = 1.36 cmH 2 O 1.0\text{ mmHg} = 1.36\text{ cmH}_2\text{O} 1.0 mmHg = 1.36 cmH 2 ​ O ):

Transducer placed below the phlebostatic axis reads falsely high pressures.

Transducer placed above the phlebostatic axis reads falsely low pressures.

Radial Arterial Line vs. Non-Invasive Cuff BP in Shock

In patients in profound distributive or cardiogenic shock receiving high-dose vasopressor therapy (e.g., high-dose norepinephrine or vasopressin), intense peripheral vasoconstriction creates a significant pressure gradient between central and peripheral arterial beds. In this setting, radial arterial blood pressure can significantly underestimate central aortic blood pressure by 20 − 30 mmHg 20-30\text{ mmHg} 20 − 30 mmHg or more. If profound discrepancy is suspected between peripheral arterial line readings and central perfusion, placement of a femoral or axillary arterial catheter provides a more accurate reflection of central aortic pressure and coronary perfusion.

Central Venous Pressure (CVP): Morphology & Limitations

Central venous pressure is measured from the distal lumen of a catheter positioned in the superior vena cava near the cavoatrial junction. Normal resting CVP in a spontaneously breathing adult is 2 2 2 to 6 mmHg 6\text{ mmHg} 6 mmHg ( 3 − 8 cmH 2 O 3-8\text{ cmH}_2\text{O} 3 − 8 cmH 2 ​ O ).

Normal Waveform Morphology

The CVP waveform reflects right atrial pressure events throughout the cardiac cycle, comprising three distinct positive deflections ( a a a , c c c , and v v v waves) and two negative deflections ( x x x and y y y descents): CVP Waveform Anatomy:

  • a v
  • / \ / \
  • / \ c / \
  • / \/\ / \
  • / \ / \
  • / x y

a a a -wave : Right atrial active contraction during end-diastole. Occurs immediately following the P wave on the surface ECG.

c c c -wave : Isovolumetric right ventricular contraction causing early bulging of the closed tricuspid valve into the right atrium. Corresponds to the end of the QRS complex.

x x x -descent : Atrial relaxation combined with the downward traction of the tricuspid valve annulus toward the cardiac apex during RV ejection. Follows the c c c -wave.

v v v -wave : Passive venous filling of the right atrium from systemic venous return against a closed tricuspid valve during late ventricular systole. Peaks near the end of the T wave.

y y y -descent : Rapid passive emptying of blood from the right atrium into the right ventricle following tricuspid valve opening in early diastole.

Pathologic CVP Waveforms

Cannon a a a -waves : Characterized by tall, prominent a a a -waves generated when the right atrium contracts against a closed tricuspid valve. They signal atrioventricular (AV) dissociation, as in complete (third-degree) heart block, ventricular tachycardia, or junctional rhythms. Distinguish them from regular giant a a a -waves , which occur with every beat when the atrium contracts against a stenotic tricuspid valve or a stiff, hypertrophied right ventricle (tricuspid stenosis, severe pulmonary hypertension).

Prominent v v v -waves (Giant Regurgitant Waves) : Severe tricuspid regurgitation directs a high-pressure jet into the right atrium during RV systole. The regurgitant volume obliterates the normal x x x -descent, fusing the c c c and v v v waves into a single tall systolic wave ("cv-wave" or "ventricularization" of the atrial waveform).

Absent a a a -waves : Loss of organized atrial mechanical contraction in atrial fibrillation or atrial flutter.

Kussmaul's Sign : A paradoxical inspiratory rise (or lack of normal inspiratory fall) in CVP during spontaneous breathing. Characteristic of constrictive pericarditis, severe right ventricular infarction, restrictive cardiomyopathy, and massive pulmonary embolism.

Steep y y y -descent : Severe tricuspid regurgitation and constrictive pericarditis (the rapid "dip-and-plateau" or square-root sign).

Attenuated or Absent y y y -descent : Cardiac tamponade. Diastolic chamber compression arrests early passive diastolic ventricular filling.

Why Static CVP Fails to Predict Fluid Responsiveness

Historically, central venous pressure was targeted to specific thresholds ( 8 − 12 mmHg 8-12\text{ mmHg} 8 − 12 mmHg ) during early goal-directed resuscitation. However, landmark systematic reviews and meta-analyses by Marik and colleagues (2008, 2013) demonstrated conclusively that static CVP has an area under the receiver operating characteristic curve (AUROC) of approximately 0.56 0.56 0.56 —equivalent to a coin flip for predicting whether a patient will increase stroke volume in response to volume administration.

Static CVP fails as a fluid responsiveness indicator because of fundamental cardiovascular physiology:

CVP is an intravascular pressure, not a volume. The relationship between right atrial pressure and right ventricular end-diastolic volume is determined by right ventricular compliance, which is highly non-linear and altered by ischemia, hypertrophy, or positive pressure ventilation.

CVP is influenced by extrathoracic factors, including positive end-expiratory pressure (PEEP), auto-PEEP, intrinsic lung compliance, chest wall rigidity, and intra-abdominal hypertension.

A patient with a CVP of 12 mmHg 12\text{ mmHg} 12 mmHg and poor RV compliance may be on the steep ascending limb of their Frank-Starling curve (preload responsive), whereas a patient with a CVP of 5 mmHg 5\text{ mmHg} 5 mmHg and dilated non-compliant cardiomyopathy may reside on the flat limb.

Pulmonary Artery Catheter (PAC): Insertion, Pressures & Complications

The pulmonary artery catheter (Swan-Ganz) is a flow-directed catheter inserted via central venous cannulation (internal jugular, subclavian, or femoral vein) that traverses the right heart into the pulmonary arterial bed.

Clinical Indications

While routine PAC placement does not improve outcomes in undifferentiated ICU populations, the PAC is clinically indicated in complex, refractory hemodynamic states:

Differentiation of mixed shock (e.g., septic shock combined with cardiogenic failure).

Refractory cardiogenic shock to guide inotropes, vasopressors, and temporary mechanical circulatory support (MCS).

Management of severe pulmonary arterial hypertension and acute right ventricular failure.

Diagnostic evaluation of suspected mechanical complications of acute myocardial infarction (ventricular septal rupture vs. acute papillary muscle rupture).

Waveform Progression During Floating

The balloon is inflated with 1.5 mL 1.5\text{ mL} 1.5 mL of air once the catheter tip enters the right atrium (at approximately 20 cm 20\text{ cm} 20 cm from the internal jugular approach), and the catheter is advanced with the venous flow while continuously observing pressure tracings: PAC Insertion Waveform Progression:

  • Right Atrium (RA) ──> Right Ventricle (RV) ──> Pulmonary Artery (PA) ──> PCWP (Wedge)
  • [Mean 2-6 mmHg] [20-30 / 0-5 mmHg] [20-30 / 8-15 mmHg] [Mean 6-12 mmHg]
  • (a, c, v waves) (Sharp systolic peak, (Dicrotic notch present, (a & v waves, loss
  • drops to zero baseline) diastolic step-up > 8) of pulsatility)

Chamber / Vessel Normal Pressure (mmHg) Waveform Morphology Key Diagnostic Landmark

Right Atrium (RA) Mean: 2 − 6 2 - 6 2 − 6 Low-amplitude undulating wave with a a a , c c c , and v v v peaks Normal venous pulsations; baseline at 20 cm 20\text{ cm} 20 cm insertion mark

Right Ventricle (RV) Systolic: 20 − 30 20 - 30 20 − 30 , Diastolic: 0 − 5 0 - 5 0 − 5 Tall, sharp systolic peak with rapid downstroke; diastolic pressure plummets to near zero Sudden appearance of high systolic pressure ( 25 mmHg 25\text{ mmHg} 25 mmHg ) with baseline near 0 mmHg 0\text{ mmHg} 0 mmHg

Pulmonary Artery (PA) Systolic: 20 − 30 20 - 30 20 − 30 , Diastolic: 8 − 15 8 - 15 8 − 15 , Mean: 10 − 20 10 - 20 10 − 20 Systolic pressure matches RV, but diastolic pressure displays a step-up ( > 8 − 10 mmHg > 8-10\text{ mmHg} > 8 − 10 mmHg ); prominent dicrotic notch Closure of the pulmonic valve produces a dicrotic notch; diastolic runoff does not touch zero

Capillary Wedge (PCWP) Mean: 6 − 12 6 - 12 6 − 12 Low-amplitude wave resembling left atrial pressure with a a a and v v v waves; respiratory variation Balloon wedges in a branch of PA; sudden loss of PA pulsatility; mean drops below PA diastolic

Physiological Validation of PCWP

PCWP reflects left atrial pressure (LAP) and approximates left ventricular end-diastolic pressure (LVEDP) under specific physiological assumptions:

There must be an uninterrupted static column of blood between the catheter tip and the left atrium. This requires the catheter tip to reside in West Zone 3 of the lung, where pulmonary arterial pressure ( P a P_a P a ​ ) and pulmonary venous pressure ( P v P_v P v ​ ) both exceed alveolar pressure ( P A P_A P A ​ ): P a > P v > P A P_a > P_v > P_A P a ​ > P v ​ > P A ​ .

If high PEEP or hypovolemia converts the catheter position to West Zone 1 or 2 ( P A > P v P_A > P_v P A ​ > P v ​ ), the catheter measures alveolar pressure rather than left atrial pressure.

Aspirating blood from the wedged port must show high oxygen tension ( P a O 2 > PaO_2 > P a O 2 ​ > systemic arterial blood) and lower P a C O 2 PaCO_2 P a C O 2 ​ , confirming pulmonary capillary blood.

PCWP overestimates LVEDP in mitral stenosis, left atrial myxoma, severe pulmonary veno-occlusive disease (PVOD), and high PEEP ( > 10 cmH 2 O > 10\text{ cmH}_2\text{O} > 10 cmH 2 ​ O ).

PCWP underestimates LVEDP in severe aortic regurgitation with premature mitral valve closure and in states of non-compliant left ventricles.

Procedural and Anatomical Complications

Conduction Block : Catheter advancement through the right ventricular outflow tract can cause transient mechanical trauma to the right bundle branch. In patients with preexisting left bundle branch block (LBBB) , this triggers acute complete heart block and ventricular asystole. Prophylactic transvenous or transcutaneous pacing must be readily available.

Ventricular Arrhythmias : Premature ventricular contractions and non-sustained or sustained VT/VF during RV transit (managed by prompt catheter advancement into the PA or withdrawal back to the RA).

Pulmonary Artery Rupture : A catastrophic complication with > 50 % > 50\% > 50% mortality presenting with massive hemoptysis. Caused by overinflation of the balloon in a small PA branch, eccentric balloon inflation, or distal migration. Management: immediate endotracheal intubation, placing the affected lung in the dependent position, balloon inflation in the proximal PA branch to tamponade the bleeding site, and emergent angiographic embolization or thoracotomy.

Pulmonary Infarction : Inadvertent persistent wedging of the balloon or catheter migration, causing branch ischemia.

  • Cardiac Output and Vascular Resistance Calculations
  • 1. Thermodilution Cardiac Output

The thermodilution technique relies on the Stewart-Hamilton equation :

C O = V i × ( T b − T i ) × K 1 × K 2 ∫ 0 ∞ Δ T b ( t ) d t CO = \frac{V_i \times (T_b - T_i) \times K_1 \times K_2}{\int_0^\infty \Delta T_b(t) \, dt} CO = ∫ 0 ∞ ​ Δ T b ​ ( t ) d t V i ​ × ( T b ​ − T i ​ ) × K 1 ​ × K 2 ​ ​

Where V i V_i V i ​ is injectate volume, T b T_b T b ​ is blood temperature, T i T_i T i ​ is injectate temperature, K 1 K_1 K 1 ​ and K 2 K_2 K 2 ​ are computation constants, and the denominator represents the area under the thermal dilution curve. A known volume ( 10 mL 10\text{ mL} 10 mL ) of cold or room-temperature saline is injected into the right atrium, and a thermistor at the catheter tip measures downstream temperature changes. Severe tricuspid regurgitation invalidates thermodilution due to retrograde thermal loss and delayed transit, leading to inaccurate (often underestimated) cardiac output.

2. The Fick Principle

The Fick principle states that total uptake of a substance by an organ is the product of blood flow to that organ and the arteriovenous concentration difference:

C O = VO 2 CaO 2 − CvO 2 = VO 2 13.4 × Hb × ( SaO 2 − SvO 2 ) CO = \frac{\text{VO}_2}{\text{CaO}_2 - \text{CvO}_2} = \frac{\text{VO}_2}{13.4 \times \text{Hb} \times (\text{SaO}_2 - \text{SvO}_2)} CO = CaO 2 ​ − CvO 2 ​ VO 2 ​ ​ = 13.4 × Hb × ( SaO 2 ​ − SvO 2 ​ ) VO 2 ​ ​

Where VO 2 \text{VO}_2 VO 2 ​ is oxygen consumption (mL/min), Hb \text{Hb} Hb is in g/dL, and saturations are expressed as fractions. While "Direct Fick" using a metabolic cart to measure real-time VO 2 \text{VO}_2 VO 2 ​ is the clinical gold standard, "Indirect Fick" utilizes an assumed VO 2 \text{VO}_2 VO 2 ​ ( 125 mL/min/m 2 125\text{ mL/min/m}^2 125 mL/min/m 2 ). In critically ill ICU patients, assumed VO 2 \text{VO}_2 VO 2 ​ introduces errors exceeding 25 % 25\% 25% due to severe metabolic alterations from fever, sepsis, sedation, or therapeutic hypothermia.

3. Systemic and Pulmonary Vascular Resistance

Vascular resistances are derived from Ohm's law analog ( R = Δ P / Q R = \Delta P / Q R = Δ P / Q ):

SVR = 80 × MAP − CVP CO \text{SVR} = 80 \times \frac{\text{MAP} - \text{CVP}}{\text{CO}} SVR = 80 × CO MAP − CVP ​

Normal range: 800 − 1200 dynes ⋅ sec ⋅ cm − 5 800 - 1200\text{ dynes}\cdot\text{sec}\cdot\text{cm}^{-5} 800 − 1200 dynes ⋅ sec ⋅ cm − 5 .

PVR = 80 × mPAP − PCWP CO \text{PVR} = 80 \times \frac{\text{mPAP} - \text{PCWP}}{\text{CO}} PVR = 80 × CO mPAP − PCWP ​

Normal PVR is below about 2 Wood units 2\text{ Wood units} 2 Wood units (roughly < 160 dynes ⋅ sec ⋅ cm − 5 < 160\text{ dynes}\cdot\text{sec}\cdot\text{cm}^{-5} < 160 dynes ⋅ sec ⋅ cm − 5 ; 1 Wood unit = 80 dynes ⋅ sec ⋅ cm − 5 1\text{ Wood unit} = 80\text{ dynes}\cdot\text{sec}\cdot\text{cm}^{-5} 1 Wood unit = 80 dynes ⋅ sec ⋅ cm − 5 ).

Under the 2022 ESC/ERS hemodynamic definitions, pulmonary hypertension is mPAP > 20 mmHg \text{mPAP} > 20\text{ mmHg} mPAP > 20 mmHg . Precapillary PH adds PCWP ≤ 15 mmHg \le 15\text{ mmHg} ≤ 15 mmHg and PVR > 2 Wood units > 2\text{ Wood units} > 2 Wood units (e.g., idiopathic PAH, chronic thromboembolic PH). Elevated mPAP with PCWP > 15 mmHg > 15\text{ mmHg} > 15 mmHg and PVR ≤ 2 Wood units \le 2\text{ Wood units} ≤ 2 Wood units indicates isolated postcapillary PH (Group 2 left heart disease); PCWP > 15 > 15 > 15 with PVR > 2 > 2 > 2 indicates combined post- and precapillary PH.

Mixed Venous ( S v O 2 SvO_2 S v O 2 ​ ) vs. Central Venous ( S c v O 2 ScvO_2 S c v O 2 ​ ) Oxygen Saturation

Venous oximetry serves as a continuous, sensitive window into the balance between systemic oxygen delivery ( DO 2 \text{DO}_2 DO 2 ​ ) and oxygen consumption ( VO 2 \text{VO}_2 VO 2 ​ ). By rearranging the Fick equation:

SvO 2 ≈ SaO 2 − VO 2 CO × 1.34 × Hb \text{SvO}_2 \approx \text{SaO}_2 - \frac{\text{VO}_2}{\text{CO} \times 1.34 \times \text{Hb}} SvO 2 ​ ≈ SaO 2 ​ − CO × 1.34 × Hb VO 2 ​ ​

Anatomical Differences: S v O 2 SvO_2 S v O 2 ​ vs. S c v O 2 ScvO_2 S c v O 2 ​

Mixed Venous Oxygen Saturation ( SvO 2 \text{SvO}_2 SvO 2 ​ ) : Sampled exclusively from the distal port of a pulmonary artery catheter. Represents true mixed venous blood thoroughly blended from the superior vena cava (head, upper extremities), inferior vena cava (viscera, kidneys, lower extremities), and coronary sinus (myocardial venous drainage, with the lowest saturation in the body: 30 − 40 % 30-40\% 30 − 40% ) inside the right ventricle. Normal range: 65 % 65\% 65% to 75 % 75\% 75% .

Central Venous Oxygen Saturation ( ScvO 2 \text{ScvO}_2 ScvO 2 ​ ) : Sampled from the distal port of a central venous catheter positioned in the lower third of the superior vena cava near the cavoatrial junction. Excludes blood returning from the inferior vena cava and coronary sinus. In healthy resting adults, ScvO 2 \text{ScvO}_2 ScvO 2 ​ is approximately 2 − 5 % 2-5\% 2 − 5% lower than SvO 2 \text{SvO}_2 SvO 2 ​ . In critically ill patients in shock, visceral and renal blood flow decreases markedly while brain perfusion is preserved; consequently, ScvO 2 \text{ScvO}_2 ScvO 2 ​ is typically 5 % 5\% 5% to 10 % 10\% 10% higher than true SvO 2 \text{SvO}_2 SvO 2 ​ . Normal range: 70 % 70\% 70% to 75 % 75\% 75% .

  • Diagnostic Interpretation of Venous Oxygen Saturation Venous Oxygen Saturation
  • │
  • ┌───────────────────────┴───────────────────────┐
  • ▼ ▼
  • Depressed (< 65%) Elevated (> 75-80%)
  • ┌─────────────────────────┐ ┌─────────────────────────┐
  • │ Decreased Delivery: │ │ Cytopathic Dysoxia: │
  • │ • Cardiogenic shock │ │ • Severe septic shock │
  • │ • Hypovolemic shock │ │ • Cyanide toxicity │
  • │ • Severe anemia │ │ • Carbon monoxide │
  • │ • Severe hypoxemia │ ├─────────────────────────┤
  • ├─────────────────────────┤ │ Microvascular Shunt: │
  • │ Increased Consumption: │ │ • End-stage cirrhosis │
  • │ • Shivering / Rigors │ ├─────────────────────────┤
  • │ • Hyperthermia / Sepsis │ │ Reduced VO2: │
  • │ • Seizures / Agitation │ │ • Hypothermia, paralysis│
  • └─────────────────────────┘ ├─────────────────────────┤
  • │ Intracardiac L-to-R: │
  • │ • Acute VSD (O2 step-up)│
  • ├─────────────────────────┤
  • │ Technical Artifact: │
  • │ • Wedged PAC port │
  • └─────────────────────────┘

Saturation State Primary Physiological Mechanism Differential Diagnosis

Depressed SvO 2 \text{SvO}_2 SvO 2 ​ ( < 65 % < 65\% < 65% ) Decreased DO 2 \text{DO}_2 DO 2 ​ (Pump failure, volume depletion, anemia, hypoxemia) Cardiogenic shock, massive pulmonary embolism, hypovolemia, severe acute anemia, acute respiratory failure ( S a O 2 < 85 % SaO_2 < 85\% S a O 2 ​ < 85% )

Depressed SvO 2 \text{SvO}_2 SvO 2 ​ ( < 65 % < 65\% < 65% ) Increased VO 2 \text{VO}_2 VO 2 ​ (Metabolic hyperconsumption) Severe shivering, malignant hyperthermia, status epilepticus, severe fever, extreme agitation, thyroid storm

Elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 75 − 80 % > 75-80\% > 75 − 80% ) Cytopathic dysoxia (Mitochondrial decoupling/inhibition) Severe septic shock (late uncoupled phase), cyanide poisoning, hydrogen sulfide toxicity

Elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 75 − 80 % > 75-80\% > 75 − 80% ) Severe microvascular shunting Advanced cirrhosis / end-stage liver disease, peripheral arteriovenous fistulae

Elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 75 − 80 % > 75-80\% > 75 − 80% ) Decreased metabolic demand ( VO 2 \text{VO}_2 VO 2 ​ ) Therapeutic hypothermia, deep pharmacological paralysis with high-dose sedation

Elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 75 − 80 % > 75-80\% > 75 − 80% ) Intracardiac Left-to-Right Shunt Acute post-MI ventricular septal rupture (demonstrating an oxygen step-up of about 5 % 5\% 5% to 7 % 7\% 7% or more between RA and RV/PA)

Elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 85 − 90 % > 85-90\% > 85 − 90% ) Technical Artifact Inadvertently wedged catheter drawing oxygenated pulmonary capillary blood

Warning

An apparently normal or elevated SvO 2 \text{SvO}_2 SvO 2 ​ ( > 75 % > 75\% > 75% ) does not rule out shock. In distributive and septic shock, severe microcirculatory bypass shunting and mitochondrial poisoning (cytopathic hypoxia) prevent peripheral cells from extracting oxygen, causing hyper-oxygenated blood to return directly to the central veins despite severe tissue dysoxia and worsening lactic acidosis.